Reaction

Platelet Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,499 reports · 53 co-occurring drugs

As of the last recalculation, Platelet Disorder appears in 2,499 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is ELTROMBOPAG OLAMINE (PRR 55.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Eltrombopag Olamine	146	55.9	56.3
Niraparib	82	31.8	31.9
Romiplostim	51	28.8	28.9
Venetoclax	111	15.7	15.7
Hydroxyurea	34	13.6	13.6
Azacitidine	35	10.0	10.0
Ruxolitinib	82	9.8	9.8
Heparin Sodium	16	9.7	9.8
Azacitidine For	21	9.7	9.7
Tranexamic Acid	10	9.4	9.4
Ticagrelor	28	7.4	7.4
Eculizumab	44	6.8	6.9
Travoprost	7	6.8	6.8
Brinzolamide	7	6.7	6.7
Brentuximab Vedotin	8	6.5	6.5
Bleomycin Sulfate	8	6.5	6.5
Avapritinib	9	6.2	6.2
Acalabrutinib	9	6.2	6.2
Nilotinib	21	6.0	6.0
Nebivolol	11	5.8	5.8
Deferasirox	18	5.7	5.7
Rucaparib	6	5.7	5.7
Ribociclib	21	5.6	5.6
Ixazomib	19	5.5	5.5
Cytarabine	39	5.5	5.5
Linezolid	19	5.3	5.4
Fulvestrant	21	5.3	5.3
Prochlorperazine	16	4.8	4.8
Ibrutinib	43	4.5	4.5
Etoposide	39	4.5	4.5
Thalidomide	19	4.3	4.3
Ravulizumab	7	4.3	4.3
Ado-Trastuzumab Emtansine	4	4.0	4.0
Peginterferon Alfa-2A	25	3.9	3.9
Palbociclib	42	3.7	3.7
Doxorubicin	39	3.7	3.7
Dasatinib	16	3.6	3.6
Obinutuzumab	7	3.6	3.6
Lenalidomide	171	3.5	3.5
Ifosfamide	9	3.5	3.5
Prasugrel Hydrochloride	4	3.3	3.3
Ribavirin	25	3.3	3.3
Irinotecan Hydrochloride	5	3.2	3.2
Olaparib	8	3.2	3.2
Sunitinib Malate	15	3.2	3.2
Temozolomide	8	3.2	3.2
Bosutinib	3	2.8	2.8
Pomalidomide	33	2.7	2.7
Peginterferon Beta-1A	4	2.5	2.5
Sarilumab	8	2.5	2.5
Abemaciclib	6	2.5	2.5
Trifluridine And Tipiracil	3	2.3	2.3
Voxelotor	4	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.